Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why MacroGenics Stock Is Tanking Today

TheMotleyFool

0 0

Shares of MacroGenics (NASDAQ: MGNX) were tanking by 19.7% as of 12:22 p.m. ET on Wednesday. The steep decline came after the company provided its first-quarter update following the market close on Tuesday.

MacroGenics reported Q1 revenue of $11.1 million, with $3.6 million in sales of breast cancer drug Margenza and the rest from collaborative agreements. This result was lower than the $16.9 million in revenue recorded in the prior-year period. It also came in well below the consensus revenue estimate of $20 million.

The company posted a net loss in the first quarter of $66.4 million, or $1.08 per share. This was worse than the average analysts' estimate of a Q1 net loss of $0.91 per share.

Source Fool.com

Like: 0

MGNX

Share